Palliative Management of Inoperable Malignant Bowel Obstruction: A Prospective, Open Label, Phase-2 Study at an NCI Comprehensive Cancer Center

Condition:   Malignant Bowel Obstruction Interventions:   Drug: Dexamethasone;   Drug: Metoclopramide;   Drug: Octreotide Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials